AF_1457 is a recombinant protein expressed in Escherichia coli as a full-length construct (1–105 amino acids) with an N-terminal His-tag for purification . Its UniProt identifier is O28815, and it is annotated as an uncharacterized protein in genomic databases .
| Parameter | Detail |
|---|---|
| Species | Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304) |
| Expression Host | E. coli |
| Tag | N-terminal His-tag |
| Protein Length | Full-length (1–105 aa) |
| Purity | ≥90% (SDS-PAGE) ; ≥85% |
Secondary Structure: No experimental data available; sequence analysis suggests potential helical or β-sheet regions.
Stability: Lyophilized powder stored at -20°C/-80°C; repeated freeze-thaw cycles are discouraged .
Reconstitution: Recommended in deionized water (0.1–1.0 mg/mL) with 5–50% glycerol for long-term storage .
While AF_1457 remains functionally uncharacterized, its recombinant availability supports exploratory research:
Protein Interactions: Potential involvement in intra-cellular processes (e.g., DNA repair, metabolic regulation), though no homologs with defined functions have been identified .
Enzymatic Activity: No catalytic activity reported; experimental validation required.
Functional Elucidation: No studies have linked AF_1457 to specific biochemical pathways or cellular processes.
Structural Determination: X-ray crystallography or cryo-EM could resolve its 3D structure.
Homology-Based Inference: Comparative genomics may identify conserved motifs or homologs in other archaea.
KEGG: afu:AF_1457
STRING: 224325.AF1457
While specific information about AF_1457 is limited in the literature, researchers can gain insights by examining the genomic neighborhood of this gene. In similar studies of A. fulgidus proteins, genomic context analysis has proven valuable. For example, the characterization of the ferric reductase encoded by the AF0830 gene involved N-terminal sequence analysis that matched to the genome sequence, confirming its identity . For AF_1457, researchers should:
Analyze flanking genes to identify potential operonic structures
Examine promoter regions for regulatory elements
Compare synteny with related archaea to identify conserved genomic neighborhoods
Assess potential horizontal gene transfer events using phylogenetic approaches
This contextual information often provides the first clues about potential functions, especially for uncharacterized proteins from extremophiles like A. fulgidus.
Expression of hyperthermophilic archaeal proteins presents unique challenges due to their extreme stability requirements and post-translational modifications. Based on successful expression of other A. fulgidus proteins such as the ferric reductase, the following expression systems are recommended:
| Expression System | Advantages | Limitations | Special Considerations |
|---|---|---|---|
| E. coli BL21(DE3) | High yield, simple cultivation | May form inclusion bodies | Lower temperature induction (16-20°C) |
| E. coli Rosetta | Enhanced translation of rare codons | More expensive | Essential for archaeal codon usage |
| Sulfolobus solfataricus | Native-like post-translational modifications | Complex cultivation | Requires specialized equipment |
| Cell-free systems | Avoids toxicity issues | Lower yield | Useful for toxic proteins |
For AF_1457, initial screening in E. coli Rosetta strains at reduced induction temperatures (16-20°C) is recommended, followed by optimization of solubility conditions and buffer compositions that reflect the native hyperthermophilic environment.
Purification of hyperthermophilic proteins benefits from their inherent stability at high temperatures. Based on successful purification strategies for other A. fulgidus proteins, a multi-step purification protocol is recommended:
Heat treatment (75-80°C) of cell lysate to precipitate most host proteins
Initial capture using ion exchange chromatography (based on predicted pI)
Intermediate purification using hydrophobic interaction chromatography
Polishing step with size exclusion chromatography
For the ferric reductase from A. fulgidus, researchers achieved 175-fold purification to homogeneity using a combination of these methods . The native enzyme was determined to be a homodimer with a molecular weight of approximately 40,000 Da, while the subunit size was approximately 18,000 Da . Similar approaches would likely be effective for AF_1457, with modifications based on its predicted properties.
Determining the function of uncharacterized proteins from extremophiles requires a multi-faceted approach:
Bioinformatic prediction:
Sequence similarity networks with known proteins
Structural homology modeling
Protein domain identification
Phylogenetic profiling
Biochemical characterization:
Substrate screening panels
Enzymatic activity assays at varying temperatures (optimal likely 85-90°C)
Cofactor requirement analysis
Metal ion dependency tests
Structural analysis:
X-ray crystallography (with and without potential substrates)
NMR spectroscopy for dynamics studies
Cryo-EM for larger complexes
In vivo studies:
Gene knockout/knockdown analysis
Protein-protein interaction studies
Transcriptional analysis under varying growth conditions
For context, the ferric reductase from A. fulgidus was identified as a novel enzyme despite sequence similarity to NAD(P)H:FMN oxidoreductases . It required detailed enzymatic characterization to reveal its unique ability to reduce Fe(3+)-EDTA using both NADH and NADPH as electron donors, with a strict requirement for FMN or FAD as catalytic intermediates .
Hyperthermophilic proteins employ several structural adaptations to maintain stability at extreme temperatures. For AF_1457, researchers should investigate:
| Adaptation Mechanism | Experimental Approach | Expected Observations |
|---|---|---|
| Increased ionic interactions | Ion-pair analysis via structural studies | Higher density of salt bridges compared to mesophilic homologs |
| Enhanced hydrophobic core packing | Fluorescence spectroscopy with hydrophobic probes | Greater resistance to chemical denaturation |
| Reduced surface loops | Limited proteolysis experiments | Fewer proteolytically sensitive regions |
| Disulfide bond stabilization | Cysteine modification studies | Strategic disulfide bonds in tertiary structure |
| Proline substitutions in loops | Circular dichroism at varying temperatures | Increased rigidity of secondary structure elements |
The ferric reductase from A. fulgidus demonstrates remarkable thermostability with a temperature optimum of 88°C and a half-life of 2 hours at 85°C . Similar thermostability assessment should be conducted for AF_1457, with careful consideration of buffer compositions that support protein integrity at these extreme temperatures.
Understanding the metabolic context of AF_1457 requires consideration of A. fulgidus' unique physiology as a hyperthermophilic sulfate-reducing archaeon:
Potential roles in energy metabolism:
Electron transfer components (similar to the characterized ferric reductase)
Alternative respiratory pathways under varying redox conditions
Stress response mechanisms to oxidative damage
Metabolic integration approaches:
Metabolomics analysis comparing wild-type and AF_1457 knockout strains
Proteomics to identify interaction partners
Transcriptional co-regulation studies
Metabolic flux analysis under varying growth conditions
Biochemical interaction studies:
Pull-down assays to identify protein complexes
Blue native PAGE for native complex identification
Crosslinking mass spectrometry to map interaction surfaces
The characterized ferric reductase in A. fulgidus plays a role in iron metabolism, specifically reducing Fe(3+)-EDTA and other Fe(3+) complexes, but not uncomplexed Fe(3+) . This selectivity suggests specialized metabolic roles that should be considered when investigating AF_1457's potential function.
Working with hyperthermophilic enzymes requires adaptation of standard enzymatic assays:
High-temperature spectrophotometric assays:
Use of sealed cuvettes to prevent evaporation
Pre-equilibration of all reagents at assay temperature
Temperature-controlled spectrophotometer chambers
Correction for temperature effects on chromophore properties
Oxygen sensitivity considerations:
Anaerobic chambers for oxygen-sensitive reactions
Oxygen-scavenging systems in buffers
Pre-degassing of all solutions
Stability of assay components:
Verification of substrate stability at high temperatures
Use of thermostable coupled enzyme systems
Time-course measurements to account for thermal degradation
For the A. fulgidus ferric reductase, researchers determined its temperature optimum at 88°C and measured enzyme activity half-life at 85°C . Similar careful temperature control and stability assessments would be essential for characterizing AF_1457.
Distinguishing thermostability determinants from catalytic features requires targeted experimental approaches:
Site-directed mutagenesis strategies:
Systematic alteration of charged residues in potential ion pairs
Substitution of conserved hydrophobic residues
Introduction of glycine residues in rigid regions
Removal/addition of proline residues in loops
Comparative analysis workflow:
Identify mesophilic homologs with similar function
Create chimeric proteins with domain swapping
Measure both thermostability and catalytic parameters
Perform molecular dynamics simulations at different temperatures
Structure-guided experimental design:
Crystallize protein at different temperatures
Conduct hydrogen-deuterium exchange mass spectrometry
Analyze B-factors in crystal structures as flexibility indicators
Use NMR to identify dynamic regions at different temperatures
The A. fulgidus ferric reductase represents an excellent example of a thermostable enzyme with unique catalytic properties, sharing sequence similarity with NAD(P)H:FMN oxidoreductases while possessing novel ferric reductase activity . This highlights how comparative approaches can reveal both structural adaptations and catalytic innovations.
Researchers often encounter contradictory results when characterizing novel proteins from extremophiles. The following methodology can help resolve such discrepancies:
Systematic validation protocol:
Verify protein identity via mass spectrometry
Confirm homogeneity by multiple methods (SEC, DLS, native PAGE)
Assess batch-to-batch variability in activity assays
Control for trace contaminants from expression host
Multi-method orthogonal validation:
Combine biochemical, biophysical, and structural approaches
Verify in vitro findings with complementary in vivo experiments
Use both heterologous expression and native protein purification
Apply isothermal titration calorimetry to directly measure binding events
Critical assessment of experimental conditions:
Evaluate buffer composition effects on activity
Test influence of reducing agents on protein behavior
Examine metal ion dependencies under strictly controlled conditions
Consider oxygen sensitivity even for presumed aerobic proteins
When the A. fulgidus ferric reductase was characterized, researchers conducted careful controls to determine that it strictly requires FMN or FAD as catalytic intermediates and that it uses both NADH and NADPH as electron donors . Similar rigorous validation would be essential for resolving any contradictory data in the characterization of AF_1457.